Human menopausal gonadotropin and the risk of epithelial ovarian cancer **Supported in part by a grant from the Joint Research Fund of the Hebrew University and Hadassah Medical Center, Jerusalem, Israel.-Reference-Cited by-同舟云学术

Human menopausal gonadotropin and the risk of epithelial ovarian cancer **Supported in part by a grant from the Joint Research Fund of the Hebrew University and Hadassah Medical Center, Jerusalem, Israel.

Published:1996-01 Issue:1 Volume:65 Page:13-18
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Shushan Asher,Paltiel Ora,Iscovich Jose,Elchalal Uri,Peretz Tamar,Schenker Joseph G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference19 articles.

1. Follicular stimulation for high tech pregnancies: are we playing it safe?;Fishel;Br Med J,1989

2. Massive hyperstimulation and borderline malignancy carcinoma of the ovary: a possible association;Atlas;Acta Obstet Gynecol Scand,1982

3. Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation—Is there a link?;Goldberg;Am J Obstet Gynecol,1992

4. Hormonal treatments and genital cancer: an update;Shushan,1993

5. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women;Whittemore;Am J Epidemiol,1992

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fertility drugs and cancer: a guideline;Fertility and Sterility;2024-09

2. Risk of borderline ovarian tumors after fertility treatment - Results from a Danish cohort of infertile women;Gynecologic Oncology;2024-06

3. Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?;Archives of Gynecology and Obstetrics;2023-09-26

4. Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis;Biomedicines;2023-06-26

5. Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis;Journal of Ovarian Research;2023-01-24